Clinical Trials Sponsored by R.O.M.A. - Rehabilitation & Outcome Measures Assessment
Total 1 results
-
R.O.M.A. - Rehabilitation & Outcome Measures AssessmentCompletedQuality of Life | Parkinson DiseaseItaly
Sponsors and Collaborators
- San MediTech(Huzhou)Co.,Ltd.
- Caritas Freetown
- Societa Italiana di Endoscopia Digestiva
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- ProteoSys AG
- Diego Hernan Giunta, MD
- University Medical Center Goettingen
- Donders Institute for Brain, Cognition and Behavior
- Rui-hua Xu, MD, PhD
- Victor Montori
- Fondren Orthopedic Group L.L.P.
- Cardresearch
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- The Fifth Affiliated Hospital of Zunyi Medical College
- Norsk Proteinintolerance, Norway
- AMTC & Associates
- Celtaxsys Aus Pty Limited
- CRMBM-CEMEREM
- Alberta Children's Hospital, Calgary, Canada
- Elim Pediatric Pharmaceuticals Inc.
- View Full List
Medical Conditions
- Stereotactic Radioablation for Ventricular Tachycardia
- Orbital Tumor
- Non-compressible Torso Hemorrhage
- Fibromyalgia Syndrome, Primary
- Spermatogenesis Arrest
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Tularaemia
- Auditory Hallucination, Verbal
- Lymphedema of Arm
- Postcomatose Unawareness State
- Gynecologic Cancer
- Non-dystrophic Myotonias
- Disturbance of Activity and Attention
- Fever, Sweats, and Hot Flashes
- Plasmodium Falciparum Malaria (Drug Resistant)
- Normal Diameter of Optic Nerve
- Atrial Fibrillation, Postoperative
- Malignant Ascites Due to Epithelial Carcinoma
- Tube Disorders Eustachian
- Prostate Cancer Recurrent
- View Full List
Drug Interventions
- Polyethylene glycol 3350
- Cytarabine ARA-C
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Mupirocin Calcium
- Topotecan
- Indoximod
- Flibanserin 100 mg dose every evening
- Lamivudine
- Methotrexate
- Enzalutamide, Abiraterone
- Atezolizumab
- Epimedium Prenylflavonoids Extract
- Bortezomib/dexamethasone
- Oxycodone, fentanyl
- Ruxolitinib
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- PF-00868554
- Cetrorelix 78 mg + 78 mg
- SERETIDE Diskus
- Insulin
- View Full List
CROs by country
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Gabon
- Contract Research Organizations in Guinea
- Contract Research Organizations in Israel
- Contract Research Organizations in Italy
- Contract Research Organizations in Malawi
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Philippines
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in United States
- CRO list by country